FDA Inspection 1205605 — Vitalant
The FDA completed an inspection of Vitalant on May 4, 2023 in Aberdeen, SD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 4, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Aberdeen, SD (United States)